Affordable Access

Publisher Website

Head down tilt 15° to preserve salvageable brain tissue in acute ischemic stroke: A pre-clinical pooled analysis, with focus on cerebral hemodynamics.

Authors
  • Diamanti, Susanna1, 2, 3, 4
  • Mariani, Jacopo1, 2, 4
  • Versace, Alessandro1
  • Riva, Matteo1
  • Cuccione, Elisa1
  • Cai, Ruiyao1
  • Monza, Laura1
  • Viganò, Martina1
  • Bolbos, Radu5
  • Chauveau, Fabien5
  • Cho, Tae-Hee5
  • Carone, Davide6
  • Ferrarese, Carlo1, 3, 4
  • Beretta, Simone1, 3, 4
  • 1 Laboratory of Experimental Stroke Research, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy. , (Italy)
  • 2 PhD Program in Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy. , (Italy)
  • 3 Department of Neurology, San Gerardo Hospital, ASST Monza, Monza, Italy. , (Italy)
  • 4 Milan Center for Neuroscience (NeuroMi), Milano, Italy. , (Italy)
  • 5 Lyon Neuroscience Research Centre; CNRS UMR5292; INSERM U1028; Univ. Lyon 1, Lyon, France. , (France)
  • 6 Acute Vascular Imaging Centre, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Type
Published Article
Journal
European Journal of Neuroscience
Publisher
Wiley (Blackwell Publishing)
Publication Date
Jun 01, 2023
Volume
57
Issue
12
Pages
2149–2159
Identifiers
DOI: 10.1111/ejn.15852
PMID: 36300727
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Neurological outcome after ischemic stroke depends on residual salvageable brain tissue at the time of recanalization. Head down tilt 15° (HDT15) was proven effective in reducing infarct size and improving functional outcome in rats with transient middle cerebral artery occlusion (t-MCAO) by increasing cerebral perfusion within the ischemic penumbra. In this pooled analysis, individual animal-level data from three experimental series were combined in a study population of 104 t-MCAO rats (45 in HDT15 group and 59 in flat position group). Co-primary outcomes were infarct size and functional outcome at 24 h in both groups. The secondary outcome was hemodynamic change induced by HDT15 in ischemic and non-ischemic hemispheres in a subgroup of animals. Infarct size at 24 h was smaller in HDT15 group than in flat position group (absolute mean difference 31.69 mm3 , 95% CI 9.1-54.2, Cohen's d 0.56, p = 0.006). Functional outcome at 24 h was better in HDT15 group than in flat position group (median [IQR]: 13[10-16] vs. 11), with a shift in the distribution of the neurobehavioural scores in favour of HDT15. Mean cerebral perfusion in the ischemic hemisphere was higher during HDT15 than before its application (Perfusion Unit [P.U.], mean ± SD: 52.5 ± 19.52 P.U. vs. 41.25 ± 14.54 P.U., mean of differences 13.36, 95% CI 7.5-19.18, p = 0.0002). Mean cerebral perfusion in the non-ischemic hemisphere before and during HDT15 was unchanged (P.U., mean ± SD: 94.1 ± 33.8 P.U. vs. 100.25 ± 25.34 P.U., mean of differences 3.95, 95%, CI -1.9 to 9.6, p = 0.1576). This study confirmed that HDT15 improves the outcome in t-MCAO rats by promoting cerebral perfusion in the ischemic territory, without disrupting hemodynamics in non-ischemic areas. © 2022 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Report this publication

Statistics

Seen <100 times